RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 65 filers reported holding RA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $147,000 | 0.0% | 6,209 | +26.2% | 0.01% | 0.0% |
| Q2 2019 | $147,000 | +32.4% | 4,919 | 0.0% | 0.01% | +11.1% |
| Q1 2019 | $111,000 | +15.6% | 4,919 | -7.4% | 0.01% | 0.0% |
| Q4 2018 | $96,000 | +60.0% | 5,311 | +62.8% | 0.01% | +80.0% |
| Q3 2018 | $60,000 | +5900.0% | 3,262 | +1276.4% | 0.01% | – |
| Q1 2018 | $1,000 | -50.0% | 237 | +200.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |